•
Jun 30, 2023

Tourmaline Bio Q2 2023 Earnings Report

Total Revenue
$0
EPS
-$3.5
Previous year: -$4.4
-20.5%
R&D Expenses
$14.5M
G&A Expenses
$1.92M
Gross Profit
-$261K
Cash and Equivalents
$152M
Previous year: $25.5M
+496.6%
Free Cash Flow
-$14.9M
Previous year: -$18.4M
-18.9%
Total Assets
$159M
Previous year: $221M
-28.0%

Tourmaline Bio

Tourmaline Bio